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ABSTRACT
The aim of this study to determine the numbers of CD34+ cells and total nucleated cell (TNC) in umbilical cord blood (UCB) 
collected from pregnant mothers with gestational diabetes mellitus (GDM) and preeclampsia (PE), following statistical 
analysis of both maternal and perinatal factors which affect UCB parameters. Most of studies explored the influence of 
obstetric factors on the number of UCB cell collection and only a few looked at the effects on UCB haematopoietic stem 
cell (UCB-HSC) of common disorders complicating pregnancy. A total of 112 UCB samples (32 PE, 42 GDM and 38 non-
diseased) were collected. CD34+ cell and NC count were enumerated using FACS Calibur. The TNC and CD34+ cells were 
significantly reduced in both PE and GDM groups as compared to the control group. The PE group shows significantly 
lower birth weight and higher BP which led to a lower UCB volume and CD34+ count. Gestational age shows significant 
correlation with nucleated cell count (NCC) and TNC. GDM group shows significantly lower systolic BP, NCC and TNC count, 
including low placental weight and birth weight. Conclusively, some obstetrics factors have significant influences to the 
numbers and quality of UCB-HSC in both PE and GDM groups, which could guide in the selection criteria for CB banking.
Keywords: CD34+ cells; gestational diabetes mellitus (GDM); haematopoietic stem cell (HSC); preeclampsia (PE); total 
nucleated cell (TNC); umbilical cord blood (UCB)
ABSTRAK
Tujuan kajian ini adalah untuk menentukan bilangan sel CD34+ dan jumlah sel bernukleus (TNC) dalam darah tali pusat 
(UCB) ibu mengandung dengan diabetes mellitus (GDM) dan  praeklampsia (PE), serta analisis statistik faktor maternal 
dan perinatal yang mempengaruhi parameter UCB. Kebanyakan kajian mengkaji pengaruh faktor obstetrik pada bilangan 
sel UCB dan hanya beberapa kajian yang melihat kesan penyakit semasa kehamilan pada kualiti UCB-HSC. Sebanyak 
112 sampel UCB (32 PE, 42 GDM dan 38 normal) diperoleh. Bilangan sel CD34+dan TNC dihitung menggunakan FACS 
Calibur. Bilangan TNC dan sel CD34+ adalah lebih rendah dalam kumpulan PE dan GDM berbanding kumpulan normal. 
Kumpulan PE menunjukkan berat bayi yang lebih rendah dan BP yang lebih tinggi yang menyebabkan jumlah isi padu 
UCB dan bilangan sel CD34+ yang lebih rendah. Faktor umur kehamilan menunjukkan korelasi yang signifikan dengan 
bilangan NC dan TNC. Kumpulan GDM menunjukkan BP sistolik, NC dan TNC yang lebih rendah, termasuk berat plasenta 
dan berat bayi yang rendah. Kesimpulannya, beberapa faktor obstetrik mempengaruhi bilangan dan kualiti UCB-HSC 
secara signifikans pada kedua-dua kumpulan PE dan GDM yang dapat membantu di dalam kriteria pemilihan untuk 
perbankan CB.
Kata kunci: Darah tali pusat (UCB); jumlah sel bernukleus (TNC); kehamilan diabetes mellitus (GDM); praeklampsia 
(PE); sel CD34+; sel stem hematopoitik (HSC)
INTRODUCTION
UCB has been used widely as an alternative source of HSC 
for transplantation. There have been over 30,000 cases of 
UCB transplantation since the first successful case to treat 
Fanconi’s anemia in 1988 and the number is increasing 
worldwide. The unique characteristics of UCB have brought 
more advantages and are promising in transplantation. It 
is capable to proliferate more than marrow and peripheral 
blood to reconstitute the host Haematopoietic pool (Ballen 
et al. 2013; Gluckman et al. 1997; Rocha et al. 2004). Also, 
it is easy to procure, acceptable of human leukocyte antigen 
mismatch, poses no risk to donor, has low risk of transmitting 
infections and is fast accessible of a graft (Broxmeyer & 
Farag 2013; Fadilah et al. 2008; Rocha et al. 2000). Despite 
advantages, there is a major limitation to the UCB use in 
transplantation. Mostly, a single unit of UCB is insufficient 
in HSC numbers and results in failure of transplantation in 
adults (Scaradavou et al. 2013; Tse & Laughlin 2005).
 Most data suggested that the dosage of cells considered 
suitable for transplantation is 1 × 107 to 3 × 107 nucleated 
2492 
cell count/kg recipients (Ballen et al. 2001). Clinical 
analyses suggested that a CD34+ cell dose of less than 1.7 × 
105 /kg had a high risk of death (Kögler et al. 1998; Wagner 
et al. 2002). From all these findings, an established policy 
have been developed by UCB banks in order to select high 
quality UCB with appropriate numbers of total nucleated 
and CD34+ cells for transplantation purposes and better 
engraftment (Ballen et al. 2001; Broxmeyer 2011; George 
et al. 2006).
 Most studies were performed to develop guidelines 
for selecting a high quality of UCB with a focus on healthy 
pregnancy. Little knowledge has been recorded about 
the effect of common disorders complicating pregnancy 
such as PE and GDM. With regard to healthy pregnancy, 
some obstetric factors such as long gestation, long labour, 
high infant and placenta weight, a short interval between 
delivery of the infant, cord clamping (Donaldson et al. 
1999), preterm delivery, route of delivery and younger 
maternal age as factors associated with higher quality 
of UCB yield (Dimitriou et al. 2006; Surbek et al. 2000). 
Jones et al. (2003) suggested that the collected volume of 
UCB will improve when a longer length of cord is left with 
the placenta and a shorter time interval exists between the 
delivery of the placenta and the collection (Jones et al. 
2003). Neonatal factors also have shown that female babies 
and bigger babies correlate with higher NCC (Ballen et al. 
2001; Nakagawa et al. 2004; Abdul Wahid et al. 2012). 
Meanwhile, a higher CD34+ cell count is observed in the 
male baby (George et al. 2006). 
 PE and GDM are among the most common medical 
disorders in pregnancy (Easterling & Benedetti 1989; 
Ismail et al. 2011). Not much information exists whether 
PE and GDM affect the quality of UCB HSC. PE was found 
to result in smaller numbers of circulating endothelial 
progenitor cells and depression of haematopoiesis in the 
foetal liver (Luppi et al. 2010; Stallmach et al. 1998). A 
few studies showed that UCB TNC and CD34+ cells were 
significantly less in PE mothers compared to normal (Abdul 
Wahid et al. 2012; Surbek et al. 2001). Meanwhile, in 
GDM pregnancy, a previous study showed CD34+ cells in 
cord blood was significantly higher compared to control 
group (Hadarits et al. 2015). Another previous study has 
compared the concentration of CD34+ cells in peripheral 
circulation of mothers with GDM, hypertension and control. 
GDM mothers had lower CD34+ compared to normal and 
hypertensive subjects (Buemi et al. 2007). In addition, 
comparing the endothelial progenitor cells (EPC) and 
CFU-EC in the umbilical cord blood of GDM mothers with 
controls, Acosta et al. (2011) found that GDM mothers had 
less EPC but there was no difference in the CFU-EC. EPC are 
not HSC but they co-express CD34+.
 Therefore, this study was performed to investigate 
the effect of PE and GDM in pregnancy on UCB HSC. This 
study will determine the quality of UCB HSC from mothers 
with either GDM or PE that may influence neonatal factors 
and their ability to proliferate in vitro. Outcome data from 
this study will be useful to decide whether the single unit 
of UCB from PE and GDM pregnancy are suitable for cryo 
banking and transplantation purposes in future, and this 
will lay a foundation for counselling mothers undergoing 
UCB banking.
MATERIALS AND METHODS
SUBJECTS
This prospective case-control study was approved by the 
Ethical Research Board of UKM Medical Centre. The study 
was conducted on 32 patients with PE, 42 patients with 
GDM and 38 healthy pregnant women who were admitted 
for delivery to the UKM Medical Centre. The diagnosis 
of PE followed the definition by the American College of 
Obstetricians and Gynaecologists (Desforges et al. 1992). 
The criteria for PE include blood pressure above 140/90 
mmHg on two readings taken 4 h apart occurring after 
20 weeks of gestation and proteinuria at least 0.3 g/L in a 
urine sample. GDM was defined according to the American 
College of Obstetricians and Gynaecologists guidelines 
with 2 h post prandial following a 75 g OGTT result and 
fructosamine during the third semester of pregnancy. The 
control group consisted of pregnant women of similar age, 
parity and gestational age without PE or GDM. All subjects 
must pass screening blood tests for hepatitis B, hepatitis 
C, cytomegalovirus, syphilis, human immunodeficiency 
virus 1-2 and haematological disorders, genetic diseases, 
pre-gestational diabetes mellitus, chronic hypertension, 
autoimmune diseases, renal or liver impairment, multiple 
pregnancies and fetal anomalies or infection. Figure 1 
shows the summary of the experimental design of the 
present study.
FIGURE 1. The summary of experimental design
  2493
SAMPLE SIZE CALCULATION
Sample size was estimated based on a study by Abdul 
Wahid et al. (2012) that looked at the effect of preeclampsia 
on the UCB hematopoietic progenitor cell by using the 
PS-Power and Sample Size Calculation Program version 
2.1.31. The power of the study was 80%.
CORD BLOOD COLLECTION
At delivery, cord blood was collected from venous UCB by 
gravity. This collection was performed before placental 
expulsion in all patients to avoid interfering with the 
delivery of the baby while still preserving the sterility of the 
UCB. The cord was clamped and cut after the delivery of the 
baby. Before delivery of the placenta, a four to eight inches 
length of the cord was cleaned with alcohol and betadine. A 
16-gauge needle from a standard cord blood collection bag 
set containing 22 mL of citrate phosphate dextrose (CPD) 
anticoagulant was inserted into the umbilical vein and cord 
blood was allowed to flow into a 157 mL bag. The needle 
was removed when blood flow stopped. Similar method 
was applied at caesarean section. Identical collection 
method was used for all three groups - PE, GDM and control. 
Collections were made by trained staff nurses accordance 
with hospital protocol. Blood samples were stored at 4°C 
immediately after collection before being collected by the 
lab outer personnel. Samples were processed within 24 h 
after collection.
NUCLEATED CELL COUNT AND CD34+ ANALYSIS
The volume of UCB was measured using a sterile tube. The 
final volume was determined by subtracting the volume of 
citrate phosphate dextrose (CPD) anticoagulant in the bag 
before collection from the total measured volume.
 UCB nucleated cells and CD34+ cell counts were 
performed using FACS Calibur analyser in accordance 
with the International Society of Hemotherapy and Graft 
Engineering (ISHAGE) (Barnett et al. 1999). Briefly, 1 mL 
of well-mixed anticoagulant UCB was syringed out from the 
cord blood collection bag into 5 mL polypropylene tube. 
Then, a 20 μL of CD45/FITC (fluorescienisothiocyanate) 
+ CD34/PE (phycoerythrin) was added to the TruCOUNT 
tube by using a pipette. The TruCOUNT tube contains a 
predisposed number of lyophilized 4.2 μm fluorescent 
beads. From the polypropylene tube, 50 μL of cord blood 
well mixed with CPD was added to the TruCOUNT tube 
using reverse pipetting technique. Another 20 μL 7-amino 
actinomycin D (7-AAD) solution was added to the sample 
as a viability dye. This allows discrimination between 
viable and non-viable cells. The mixture was gently mixed 
immediately after both reagents had been added. It was 
incubated for 15 min in the dark at room temperature (20° 
to 25°C). After incubation, the remaining red blood cells 
in the sample tube were lysed with 1 mL 1:10 dilution of 
lysing solution BD Pharm Lyse reagent (BD Biosciences) for 
10 min. Then, 75000 events were acquired and analysed by 
three colour flow cytometry using Cell Quest Pro software 
(Becton Dickinson). Figure 2 shows an example of Dot 
Plot graph generated from FACS analysis of one control 
sample. The absolute and total numbers of nucleated (TNC) 
and CD34  + cell were counted using formulary according to 
manufacturer’s protocol. 
CLINICAL DATA COLLECTION
Clinical data for both mother and newborn will be recorded 
for further interpretation and statistical analysis. Maternal 
data includes age, gestational age, blood pressure, delivery, 
gravidity, cord pH, pre-delivery leukocytes and type of 
anti-diabetic and anti-hypertensive treatment. For the 
newborn, weight, gender, placental weight and 1 and 5 
min Apgar scores will be recorded.
STATISTICAL ANALYSIS
The statistical software package SPSS version 16.0 was 
used to perform the data analysis. Data will be tested for 
 A B C
A) Threshold on FL1 channel of all events collected for this particular sample; R3 defines population of CD45+ leucocytes (except blue coloured dot defines as beads), R5 
defines CD34+ population, and R8 defines the lymphocyte population of interest. B) Distinguished populations of live (selected population for further analysis), and dead 
cells (R2) by 7-AAD staining. C) CD45+ cells with distinguished CD34+ cells population (R4) and TruCOUNT beads (R1)
FIGURE 2. Dot plot graph generated from FACS analysis of one control sample
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normality using the Shapiro-Wilk test. Continuous data 
were analysed using the analysis of variance (ANOVA) 
test, while categorical data were compared using the chi 
square test. Pearson’s product-moment correlation and 
Spearman’s rank order correlation were used to study the 
relationship between maternal and neonatal factors and CB 
parameters among PE and GDM subjects. A p-value < 0.05 
was considered to be statistically significant.
RESULTS AND DISCUSSION
THE PE GROUP SHOWS SIGNIFICANT CORRELATIONS IN 
BOTH MATERNAL AND PERINATAL CHARACTERISTICS AS 
COMPARED TO THE CONTROL GROUP
Maternal and perinatal characteristics data of the GDM, PE 
and control groups were summarized in Table 1. There were 
32 PE, 42 GDM and 38 non-diseased subjects (control). There 
were no statistically significant differences between the 
groups in terms of maternal and perinatal factors including 
maternal leukocyte count, placental weight and neonatal 
gender. There was a significant difference in maternal age 
between the control group and the PE group (p=0.004), but 
not difference in GDM group. We predicated subjects with 
GDM were an elderly which is above 35 years old. However, 
the average maternal age for subject with GDM is 30.74 
years old. This finding were contradicting with the previous 
study which reported, women aged 35 years and above are 
more likely to have GDM (Kalok et al. 2018). As expected, 
systolic and diastolic BP were significantly higher in the PE 
group compared to the control group (p=<0.0005), and the 
GDM group (p=<0.0005). We found that gestational age was 
also significantly different in the PE group compared to the 
control group (p=<0.0005) and the GDM group (p=0.031). 
In terms of route of delivery, the control group showed 
significant differences with the PE (p=<0.0005) and the 
GDM group (p=0.013), with spontaneous vaginal delivery 
(SVD) being more common in the control group. Gravidity 
1-3 in the control group is higher compared to the PE group 
(p=0.028), and showed no significant difference with the 
TABLE 1. Maternal & perinatal characteristics data
Parameters Control group
PE 
group
GDM 
group P value
Maternal age (y) 29.79± 0.53 32.69 ± 0.83 30.74 ± 0.61
Control vs GDM = 0.254
Control vs PE = 0.004*
GDM vs PE = 0.060
Gestational age (wk) 38.55± 0.19 36.39 ± 0.48 37.89 ± 0.22
Control vs GDM =0.031*
Control vs PE = <0.0005**
GDM vs PE = 0.003*
Maternal leukocyte 
count (×109/L) 11.06± 0.43 11.22 ± 0.51 11.04 ± 0.53
Control vs GDM = 0.978
Control vs PE = 0.809
GDM vs PE = 0.814
Gravidity
1-3
4-6
32 (94.1%)
2 (5.9%)
19 (67.8%)
9 (32.2%)
32 (82.1%)
7 (17.9%)
Control vs GDM = 0.268
Control vs PE = 0.028*
GDM vs PE = 0.365
Systolic BP (mmHg) 120.21± 1.81 158.21 ± 3.49 120.74 ± 1.57
Control vs GDM = 0.825
Control vs PE = <0.0005**
GDM vs PE = <0.0005**
Diastolic BP (mmHg) 69.38± 1.47 96.03 ± 2.44 70.94 ± 1.49
Control vs GDM =0.459
Control vs PE = <0.0005**
GDM vs PE =<0.0005**
Delivery
SVD
LUSCS
33 (97.1%)
1 (2.9%)
16 (57.1%)
12 (42.9%)
30 (76.9%)
9 (23.1%)
Control vs GDM = 0.013*
Control vs PE = <0.0005**
GDM vs PE = 0.088
Birth weight (g) 3.08± 0.58 2.72 ± 0.10 3.03 ± 0.07
Control vs GDM = 0.639
Control vs PE = 0.002*
GDM vs PE = 0.011*
Placental weight (g) 600± 15.71 550.47 ± 22.77 582.70 ± 16.81
Control vs GDM = 0.459
Control vs PE = 0.07
GDM vs PE = 0.257
Fetal gender
Male
Female
13 (38.2%)
21 (61.8%)
17 (60.7%)
11 (39.3%)
21 (53.8%)
18 (46.2%)
Control vs GDM = 0.185
Control vs PE = 0.080
GDM vs PE = 0.185
Values shown are mean ± SEM. p is significant if <0.05. ANOVA-test. Fisher’s exact test. *Significant. **Highly significant
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GDM group. Additionally, birth weight in the PE group is 
smaller compared to the control (p=0.002) and GDM groups 
(p=0.011) with significant differences. However, most 
parameters did not show differences between the control 
group and GDM groups.
TNC AND CD34+ CELLS WERE SIGNIFICANTLY REDUCED 
IN BOTH THE PE AND GDM GROUPS AS COMPARED                       
TO CONTROL GROUP
Table 2 shows summary of UCB parameters of all patients’ 
groups. All parameters in the control group including 
volume, nucleated cell count, total nucleated count, CD34+ 
count and total CD34+ count were significantly higher as 
compared to the GDM and PE groups. 
 We found that UCB parameters were significantly 
reduced in mothers affected by PE and GDM compared to 
the healthy pregnant mothers. These parameters include 
volume, TNC and CD34+ count. In the PE group, our 
findings are consistent with previous published report. 
Stallmach et al. (1998) reported that PE led to less erythroid 
precursors and early granulopoietic cells in foetal livers 
and alteration of foetal haematopoiesis. This situation 
gives rise to alteration of cytokines and growth factor 
level in foetal blood. The long term alteration pattern of 
the haematopoietic growth factors and cytokines in the 
foetus might have influence on haematopoietic activity 
in the progenitor cell population (Surbek et al. 2001). 
The abnormalities in the placenta due to PE also may 
affect the ability of haematopoietic stem cells to grow 
and differentiate (Santillan et al. 2013). In the GDM 
group, the effects of GDM on UCB HSC have not been well 
studied. The mechanism by which this disease affects the 
UCB HSC is almost the same as in PE (Hadi & Al Suwaidi 
2007). A few studies showed that such adverse conditions 
exist in pregnancies complicated by GDM, which tend to 
associate placental anatomy with physiological alterations. 
Mainly, the changes affect the micro-anatomical and 
molecular levels including aberrant villous vascularization. 
Angiogenesis facilitating functions might be altered and 
circulating haematopoietic progenitor cells will be reduced 
in the cord blood of GDM pregnancies (Gauster et al. 2011). 
However, this result is contradicts with Hadarits et al. 
(2015) that showed significantly higher CD34+ cells in 
mothers with GDM. This might be explained by different 
population of subjects, whereas Europe region compared 
to this study in Malaysia. Besides, Hadarits et al. (2015) 
cannot conclude the definite finding due to the small sample 
sizes. These results should be confirmed in other larger 
cohort study to come with absolute conclusion.
 TNC is one of the parameters that should be considered 
before processing UCB unit. We showed that TNC obtained 
from healthy pregnant mothers is (9.36 ± 0.62 × 108 cells) 
50% more than the medical disorders group. However, 
there were no significant differences between the PE and 
GDM groups. TNC content that requires UCB processing 
and storage is 6 to 10 × 108 cells (Jaime-Perez et al. 2011). 
In contrary, in a study by Nakagawa et al. (2004), the 
threshold for processing and cryopreservation was set at 
4 × 108 TNC, hence it is unlikely that the UCB unit collected 
from PE and GDM mothers in our study will be selected for 
processing and storage. The TNC dose for transplantation is 
very important and significantly related to post-transplant 
survival and transplantation related mortality. Acceptable 
dose considered for transplantation is in the range of 1 
to 3 × 107 TNC/kg recipient weights. Higher dose of TNC 
will reduce percentage of death (Donaldson et al. 1999). 
The cut-off value of 8 × 108 cells or more as standard 
TNC dose correlates with adequate numbers of CD34+ for 
cryopreservation for grafting purposes.
 CD34+ count is another parameter that will influence 
the outcome of engraftment and transplantation related 
mortality (TRM) including survival post-transplantation. 
TABLE 2. Summary of UCB parameters in all patients groups
Variable Control Group PE Group GDM Group P Value
Volume (mL) 102.16 ± 2.43 91.43 ± 2.55 80.36 ± 1.88
Control vs GDM = <0.0005**
Control vs PE = 0.003*
GDM vs PE = 0.001*
Nucleated Cell (× 106 cells/mL) 9.03 ± 0.46 4.21 ± 0.41 4.74 ± 0.30
Control vs GDM = <0.0005**
Control vs PE = <0.0005**
GDM vs PE = 0.293
Total Nucleated Cell (× 108 cells) 9.36 ± 0.62 3.96 ± 0.44 3.87 ± 0.29
Control vs GDM = <0.0005**
Control vs PE = <0.0005**
GDM vs PE = 0.853
CD34+ (cells/μL) 125.60 ± 9.75 67.17 ± 5.47 61.18 ± 6.64
Control vs GDM = <0.0005**
Control vs PE = <0.0005**
GDM vs PE = 0.507
Total CD34+ (× 106 cells) 13.07 ± 1.11 6.28 ± 0.57 4.88 ± 0.55
Control vs GDM = <0.0005**
Control vs PE = <0.0005**
GDM vs PE = 0.086
Values shown are mean ± SEM. p is significant if <0.05. ANOVA test. *Significant. **Highly significant
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High dose of CD34+ cells is crucial for hematopoietic 
engraftment (Fadilah et al. 2013). One study showed that 
patients who received 1.7 × 105 CD34+/kg or higher will 
have lower TRM compared to those who receive lower 
than 1.7 × 105 CD34+/kg (Wagner et al. 2002). By using 
this threshold, UCB collected from PE mothers in our study 
would be suitable for recipients with body weight of less 
than 40 kg and for UCB obtained from GDM mothers would 
be suitable for recipients with body weight of less than 28 
kg. Henceforth, we suggest that UCB units from pregnancies 
complicated by such medical disorder should not be used 
in adult patients. These UCB units would only be beneficial 
for babies or children or young small built adolescents.
THE PE GROUP SHOWS SIGNIFICANTLY LOWER BIRTH 
WEIGHT AND HIGHER SYSTOLIC BP AND DIASTOLIC BP 
WHICH LED TO A LOWER UCB VOLUME
We further analysed the correlation between maternal and 
neonatal factors with UCB parameters in the PE group as 
shown in Table 3. Gestational age and birth weight were 
statistically significantly associated with NCC and TNC. 
The birth weight, Systolic BP and diastolic BP were the 
main significant factors affecting the low volume of UCB. 
Meanwhile, an increased systolic BP showed significant 
correlation with reduced counts of CD34+ cell/μL (p=0.046) 
and total CD34+ count (p=0.013) and increase diastolic BP 
also showed significant correlation with reduced counts 
of CD34+ cell/μL (p=0.020). In addition, maternal age, 
maternal WCC, gravidity, route of delivery, placental 
weight and neonatal gender did not show any significant 
correlation with all UCB parameters.
 Upon scrutinizing the relationship between maternal 
and neonatal factors and UCB parameters in PE pregnancies, 
we found that systolic BP and diastolic BP have significant 
effect on UCB volume and total CD34+ count. PE mothers 
with higher systolic readings have reduced volumes, CD34+ 
counts and total CD34+ counts. Meanwhile, PE mothers with 
higher diastolic readings have reduced volumes and CD34+ 
counts. These findings were consistent with a previous 
study that showed the severity of PE affects the volume, 
CD34+ count and total CD34+ count negatively (Abdul 
Wahid et al. 2012; Surbek et al. 2001). We found bigger 
birth weights increases cord blood volume, NCC and TNC. 
Our data is consistent with a previous study in normal 
pregnancy that bigger babies were associated with larger 
cord blood volumes and higher TNC counts (McGuckin et 
al. 2007). However, birth weight did not influence CD34+ 
cell/μL and total CD34+ cell count. This data was not 
consistent with prior studies on non-PE mothers, perhaps 
because of the high volume of cord blood in the PE group, 
which is almost similar to the control group in the earlier 
result. This high volume of cord blood contributes towards 
high total CD34+ counts as it depends on the blood volume. 
TABLE 3. The association between maternal & perinatal factors and UCB parameters in PE group
Factor Volume (mL)
Nucleated cell 
(106 cells/ mL)
Total nucleated 
cell (×108 cells)
CD34+ 
(cells/μL)
Total CD34+ 
(×106 cells)
Maternal age (years)
  P value
  r value
0.716
-0.092
0.320
-0.249
0.229
-0.298
0.701
-0.097
0.629
-0.122
Gestational age (weeks)
  P value
  r value
0.983
-0.005
<0.0005**
0.631
<0.0005**
0.660
0.626
0.123
0.561
0.147
Maternal white cell count
  P value
  r value
 Gravidity
 Route of delivery
0.894
0.035
0.583
0.704
0.709
-0.098
0.183
0.399
0.619
-0.130
0.257
0.223
0.286
-0.275
0.257
0.925
0.232
-0.306
0.218
0.925
Systolic blood pressure (mmHg)
  P value
  r value
<0.0005**
-0.746
0.885
-0.031
0.198
-0.266
0.046*
-0.380
0.013*
-0.463
Diastolic blood pressure (mmHg)
  P value
 r value
0.009*
-0.487
0.853
-0.039
0.393
-0.179
0.020*
-0.437
0.172
-0.282
Placental weight (g)
  P value
  r value
0.256
0.259
0.416
0.227
0.236
0.326
0.943
0.020
0.523
0.179
Birth weight (g)
  P value
  r value
 Baby gender
0.019*
0.450
0.396
0.001*
0.613
0.588
0.001*
0.591
0.961
0.406
0.216
0.349
0.232
0.306
0.588
P is significant if <0.05. Spearman’s rank order test. Mann-Whitney µ-test.*significant. ** Highly significant.
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Another possible explanation is the small sample size 
(n=32) compared to other studies. But one study with a 
huge cohort sample size (n=>8000) reported that birth 
weight was not strongly related to HSC count (Cairo et 
al. 2005), thus supporting the theory that altered foetal 
haematopoiesis is a consequence of PE itself rather than 
growth restriction alone as the UCB volume and numbers 
of HSC was smaller in the PE group compared to healthy 
pregnancies, regardless of birth weight (Hiett et al. 1995).
GDM GROUP SHOWS SIGNIFICANTLY LOWER SYSTOLIC BP, 
LOW PLACENTAL WEIGHT AND BIRTH WEIGHT 
WITH LOWER NCC AND TNC
The correlation between maternal and neonatal factors with 
UCB parameters in the GDM group were further analysed 
as shown in Table 4. We found that the placental weight 
significantly lowered the volume of cord blood (p=0.015). 
Both NCC and TNC were significantly reduced with lower 
systolic BP (p=0.007; p=0.017), including a decreased of 
placental weight (p=<0.0005; p=<0.0005) and birth weight 
(p=0.017; p=0.011). Other factors showed no correlation 
with UCB parameters.
 In the GDM group, we found that maternal age, 
gestational age, maternal white cell count, gravidity, 
delivery and diastolic pressure had no association with 
UCB parameters. However, systolic BP showed positive 
significant influence on NC and TNC only. Higher systolic BP 
increases NC and TNC counts. However, no previous studies 
reported any correlation between maternal factors and UCB 
parameters. In a study by Abdul Wahid et al. (2012), it 
was shown that in healthy pregnancies lower systolic BP 
correlated with an increase in NC and TNC counts. The exact 
mechanism involving GDM which leads to an increase in 
NC and TNC counts is not exactly understood but we believe 
that vascular endothelial dysfunction or inflammation may 
play a role. A larger sample size may serve to further unveil 
the patterns in UCB parameters.
 Among neonatal factors, birth weight had significant 
correlations with NC and TNC counts and placental weight 
appeared to influence volume, NC and TNC. Our study found 
that there was no significant difference in placental weight 
between healthy mothers and GDM mothers. This finding 
is not in line with a previous study which reported that the 
placentae of diabetic women were larger, thicker, more 
plethoric, and associated with macrosomia (Radaelli et al. 
2003). Good glycaemic control among our GDM subjects 
may be the reason for the normal placental and birth weight. 
This is in agreement with previous study which reported 
macrosomia is less common in GDM subject with good 
glycaemic control (Kampan et al. 2013). However, GDM 
affects the angiogenic factors in placentae with decreased 
UCB parameters. In addition, our data showed that higher 
placental weight will increase the volume, NC and TNC of 
UCB in GDM mothers, without any association with CD34+ 
TABLE 4. The association between maternal & perinatal factors and UCB parameters in GDM group
Factor Volume (mL)
Nucleated cell 
(106 cells/ mL)
Total nucleated 
cell (×108 cells)
CD34+ 
(cells/μL)
Total CD34+ 
(×106 cells)
Maternal age (years)
  P value
  r value
0.119
0.254
0.262
-0.184
0.836
-0.034
0.317
-0.165
0.527
-0.104
Gestational age (weeks)
  P value
  r value
0.525
-0.105
0.868
0.028
0.940
-0.013
0.471
-0.119
0.406
-0.137
Maternal white cell count
  P value
  r value
 Gravidity
 Route of delivery
0.182
-0.225
0.142
0.520
0.623
-0.083
0.475
0.368
0.280
-0.182
0.884
0.424
0.974
-0.005
0.107
0.351
0.817
-0.039
0.213
0.194
Systolic blood pressure (mmHg)
 P value
  r value
0.226
0.201
0.007*
0.433
0.017*
0.387
0.484
0.117
0.290
0.176
Diastolic blood pressure (mmHg)
  P value
  r value
0.512
-0.110
0.886
-0.024
0.635
-0.080
0.720
-0.060
0.563
-0.097
Placental weight (g)
  P value
  r value
0.015
0.382
<0.0005**
0.549
<0.0005**
0.583
0.621
0.084
0.268
0.187
Birth weight (g)
  P value
  r value
 Baby gender
0.160
0.229
0.253
0.017*
0.381
0.143
0.011*
0.401
0.139
0.448
0.125
0.384
0.197
0.211
0.196
p is significant if <0.05. Spearman’s rank order test. Mann-Whitney µ-test.*significant. ** Highly significant
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and total CD34+ cell count. Since volume and TNC are the 
current standard practice for UCB cryopreservation, we can 
consider placental weight in GDM mothers as an additional 
factor that contributes to the UCB parameters.
CONCLUSION
From this study, we can conclude that medical disorders in 
pregnancy, namely PE and GDM, affect the quality of UCB 
HSC. The numbers of NCC from pregnancies affected by 
these disorders are shown to be lower than the international 
standards. Still, this parameter remains as an important 
marker for UCB processing and cryopreservation. In 
addition, several factors such as gestational age, systolic 
BP, placental weight and birth weight should be taken into 
consideration when mothers with PE consider undergoing 
CB banking. Meanwhile, in GDM mothers, factors such 
as systolic BP, placental weight and birth weight should 
also be considered when selecting good quality UCB for 
CB banking. Future studies involving larger sample sizes 
may help to further confirm these findings for efficient 
CB banking.
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